Shankar Lakshmi, Smith Nicole, Uchino Ken, Thompson Nicolas R, Pozuelo Leopoldo, Katzan Irene L
Neurological Institute, Cleveland Clinic, Cleveland, Ohio.
Neurological Institute, Cleveland Clinic, Cleveland, Ohio; Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2519-2526. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.044. Epub 2017 Jul 26.
The ideal time to screen for poststroke depression remains uncertain. We evaluated the 2-item Patient Health Questionnaire (PHQ-2) as a screening tool for depression during the acute stroke admission by determining the prevalence of positive depression screen during admission and by calculating the level of agreement between positive screens during admission and follow-up.
This was a retrospective cohort of adult stroke survivors discharged January to December 2013 with principal discharge diagnosis of acute ischemic stroke or intracerebral hemorrhage. Depression screening was systematically performed during the hospital admission using the PHQ-2. The 9-item Patient Health Questionnaire (PHQ-9), which includes the PHQ-2, was completed by patients at outpatient follow-up.
The study cohort consisted of 337 patients with mean age of 66.3 years. Median time from admission to PHQ-2 was 3 days (interquartile range 1-4 days). The screen was positive for depression in 4.7% (95% confidence interval 2.7%-7.6%) of patients. Of the 150 patients with PHQ-9 data at outpatient follow up, 19.3% screened positive for depression. In both the inpatient setting and at outpatient follow-up, the prevalence of a positive depression screen was similar between patients with and without a history of depression or antidepressant use.
Systematic screening for depression using PHQ-2 during hospitalization for acute stroke identified few patients. Most patients with depressive symptoms were identified only at the time of outpatient follow-up. Further study is needed to evaluate the usefulness of other depression screens for stroke patients in the acute hospital setting and the optimal timing for depression screening after stroke.
卒中后抑郁的理想筛查时间仍不确定。我们通过确定急性卒中入院期间抑郁筛查阳性的患病率,并计算入院时与随访期间阳性筛查的一致性水平,评估了两项患者健康问卷(PHQ-2)作为急性卒中入院期间抑郁筛查工具的效果。
这是一项回顾性队列研究,研究对象为2013年1月至12月出院的成年卒中幸存者,主要出院诊断为急性缺血性卒中或脑出血。在住院期间使用PHQ-2系统地进行抑郁筛查。患者在门诊随访时完成包含PHQ-2的九项患者健康问卷(PHQ-9)。
研究队列包括337例患者,平均年龄66.3岁。从入院到进行PHQ-2筛查的中位时间为3天(四分位间距1 - 4天)。4.7%(95%置信区间2.7% - 7.6%)的患者抑郁筛查呈阳性。在150例有门诊随访PHQ-9数据的患者中,19.3%的患者抑郁筛查呈阳性。在住院和门诊随访中,有抑郁病史或使用过抗抑郁药的患者与无此类病史的患者之间,抑郁筛查阳性的患病率相似。
在急性卒中住院期间使用PHQ-2进行抑郁系统筛查仅发现了少数患者。大多数有抑郁症状的患者仅在门诊随访时才被发现。需要进一步研究来评估其他抑郁筛查工具对急性医院环境中卒中患者的有效性以及卒中后抑郁筛查的最佳时机。